Showing results (251-260 of 312) with videos related to

Sort By:
Pageof 32
NPJ Precision Oncology|July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
ESMO Open|September 13, 2023
Genomic characterization of thymic epithelial tumors in a real-world datasetK Kurokawa, T Shukuya, R A Greenstein, et al.
The Oncologist|June 3, 2021
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsMason A Israel, Natalie Danziger, Kimberly A McGregor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesErik A Williams, Nikunj Shah, Meagan Montesion, et al.
Science Translational Medicine|December 9, 2016
Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's diseaseAnamitra Ghosh, Trevor Tyson, Sonia George, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2020
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutationsErik A Williams, Meagan Montesion, Nikunj Shah, et al.
JACC. Cardiovascular Imaging|April 10, 2009
Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy systemCraig M Gardner, Huwei Tan, Edward L Hull, et al.
The Oncologist|July 26, 2022
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling StudyAndrea Necchi, Philippe E Spiess, Marco Bandini, et al.
Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.
Pageof 32